Company page

Alpha Cognition Inc.

Alpha Cognition Inc. (Ticker: ACOG) is a public company operating in the American market, with a market capitalization of approximately $172 million. The company focuses on developing innovative therapies for neurological diseases. Its commitment to advancing healthcare solutions positions it as a notable player in the biotechnology sector.